216 related articles for article (PubMed ID: 28572054)
21. A revival of the B cell paradigm for rheumatoid arthritis pathogenesis?
Benoist C; Mathis D
Arthritis Res; 2000; 2(2):90-4. PubMed ID: 11094418
[TBL] [Abstract][Full Text] [Related]
22. The role of autoreactive T cell in the pathogenesis of rheumatoid arthritis and implications for T cell targeted vaccine therapy.
Wang D; Li Y; Liu Y; Shi G
Minerva Med; 2015 Jun; 106(3):157-67. PubMed ID: 26057192
[TBL] [Abstract][Full Text] [Related]
23. Rheumatoid arthritis: Biological therapy other than anti-TNF.
Rossi D; Modena V; Sciascia S; Roccatello D
Int Immunopharmacol; 2015 Aug; 27(2):185-8. PubMed ID: 25840282
[TBL] [Abstract][Full Text] [Related]
24. The roles of B cells and their interactions with fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis.
Wang Q; Ma Y; Liu D; Zhang L; Wei W
Int Arch Allergy Immunol; 2011; 155(3):205-11. PubMed ID: 21293141
[TBL] [Abstract][Full Text] [Related]
25. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?
Panayi GS
Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii3-ii7. PubMed ID: 15851524
[TBL] [Abstract][Full Text] [Related]
26. Memory B Cells and Response to Abatacept in Rheumatoid Arthritis.
Gazeau P; Alegria GC; Devauchelle-Pensec V; Jamin C; Lemerle J; Bendaoud B; Brooks WH; Saraux A; Cornec D; Renaudineau Y
Clin Rev Allergy Immunol; 2017 Oct; 53(2):166-176. PubMed ID: 28477078
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-21 signaling in B cells, but not in T cells, is indispensable for the development of collagen-induced arthritis in mice.
Sakuraba K; Oyamada A; Fujimura K; Spolski R; Iwamoto Y; Leonard WJ; Yoshikai Y; Yamada H
Arthritis Res Ther; 2016 Aug; 18():188. PubMed ID: 27535236
[TBL] [Abstract][Full Text] [Related]
28. The pathogenesis of rheumatoid arthritis: new insights from old clinical data?
Smolen JS; Aletaha D; Redlich K
Nat Rev Rheumatol; 2012 Mar; 8(4):235-43. PubMed ID: 22410633
[TBL] [Abstract][Full Text] [Related]
29. Inhibiting costimulatory activation of T cells : a viable treatment option for rheumatoid arthritis?
Pollard LC
Drugs; 2007; 67(1):1-9. PubMed ID: 17209660
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
Nakayamada S; Kubo S; Yoshikawa M; Miyazaki Y; Yunoue N; Iwata S; Miyagawa I; Hirata S; Nakano K; Saito K; Tanaka Y
Rheumatology (Oxford); 2018 Jan; 57(1):164-174. PubMed ID: 28371836
[TBL] [Abstract][Full Text] [Related]
31. Lymphocyte populations in rheumatoid arthritis.
Herrera-Esparza R; Limas del Muro E; Macías-Román MD; Aguilera-Aguilera R
Arch Invest Med (Mex); 1981; 12(2):153-61. PubMed ID: 7023411
[TBL] [Abstract][Full Text] [Related]
32. [Effect of CTLA4-Ig on radiographic outcome of patients with rheumatoid arthritis].
Harigai M
Clin Calcium; 2007 Apr; 17(4):577-84. PubMed ID: 17404488
[TBL] [Abstract][Full Text] [Related]
33. Targeted therapy in rheumatoid arthritis.
Köller MD
Wien Med Wochenschr; 2006 Jan; 156(1-2):53-60. PubMed ID: 16465614
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis.
Vierboom MP; Breedveld E; Kap YS; Mary C; Poirier N; 't Hart BA; Vanhove B
Clin Exp Immunol; 2016 Mar; 183(3):405-18. PubMed ID: 26540618
[TBL] [Abstract][Full Text] [Related]
35. Altered T lymphocyte signaling in rheumatoid arthritis.
Allen ME; Young SP; Michell RH; Bacon PA
Eur J Immunol; 1995 Jun; 25(6):1547-54. PubMed ID: 7614981
[TBL] [Abstract][Full Text] [Related]
36. Prospective new biological therapies for rheumatoid arthritis.
Senolt L; Vencovský J; Pavelka K; Ospelt C; Gay S
Autoimmun Rev; 2009 Dec; 9(2):102-7. PubMed ID: 19328245
[TBL] [Abstract][Full Text] [Related]
37. Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma.
Cheah CY; Fowler NH; Neelapu SS
Curr Opin Oncol; 2015 Sep; 27(5):384-91. PubMed ID: 26248256
[TBL] [Abstract][Full Text] [Related]
38. Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis.
Chen L; Lu Y; Wang F; Zhou M; Chu Y; Ding W; Liu C; Xie J; Wu C; Jiang J
Immunol Lett; 2013; 154(1-2):25-30. PubMed ID: 23973734
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.
Bommarito D; Hall C; Taams LS; Corrigall VM
Clin Exp Immunol; 2017 Jun; 188(3):455-466. PubMed ID: 28245522
[TBL] [Abstract][Full Text] [Related]
40. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
Baslund B; Bendtzen K
Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
